Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Brian Rossmiller"'
Autor:
Zhao-Yang Wang, Keke Zhao, Jingwei Zheng, Brian Rossmiller, Cristhian Ildefonso, Manas Biswal, Pei-quan Zhao
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88324 (2014)
PurposeTo investigate whether the polymorphism rs800292 (184G>A, I62V) in the complement factor H gene is associated with polypoidal choroidal vasculopathy (PCV) and the genetic difference between PCV and neovascular age-related macular degeneration
Externí odkaz:
https://doaj.org/article/d60e07cefae04e3bb5a036c1a7b5c13f
Autor:
Gustavo D. Aguirre, Alfred S. Lewin, Valerie L. Dufour, Artur V. Cideciyan, Raghavi Sudharsan, Luis Felipe Marinho, Tatyana Appelbaum, Michael T. Massengill, Brian Rossmiller, Alexander Sumaroka, Malgorzata Swider, William W. Hauswirth, Brianna Lisi, William A. Beltran, Samuel G. Jacobson, Simone Iwabe
Publikováno v:
Proceedings of the National Academy of Sciences. 115
Inherited retinal degenerations are caused by mutations in >250 genes that affect photoreceptor cells or the retinal pigment epithelium and result in vision loss. For autosomal recessive and X-linked retinal degenerations, significant progress has be
Publikováno v:
Human Gene Therapy. 23:356-366
Many mutations in the human rhodopsin gene (RHO) cause autosomal dominant retinitis pigmentosa (ADRP). Our previous studies with a P23H (proline-23 substituted by histidine) RHO transgenic mouse model of ADRP demonstrated significant improvement of r
Publikováno v:
Acta ophthalmologica. 94(4)
Purpose Four-port bimanual vitrectomy is a surgical technique that facilitates removal of epiretinal membranes in severe proliferative diabetic retinopathy (PDR). As the illumination is held by the assistant through the fourth scleral incision, fibro
Publikováno v:
Molecular Therapy. 23
Retinitis pigmentosa is the leading hereditary cause of blindness with 30-40% of cases attributable to autosomal dominant retinitis pigmentosa (ADRP). ADRP arises from mutations in at least 24 known genes with 30% arising in the rhodopsin gene (RHO).
Publikováno v:
Methods in Molecular Biology ISBN: 9781493923298
Retinal gene therapy has proven safe and at least partially successful in clinical trials and in numerous animal models. Gene therapy requires characterization of the progression of the disease and understanding of its genetic cause. Testing gene the
Publikováno v:
Cold Spring Harbor perspectives in medicine. 4(9)
As many as 40% of retinitis pigmentosa cases display autosomal dominant inheritance, and approximately one quarter of these are attributable to mutations in RHO, the gene for rod cell opsin (Sullivan et al. 2006). A complicating feature of RHO-based
Autor:
Peiquan Zhao, Manas R. Biswal, Brian Rossmiller, Zhao-Yang Wang, Cristhian J Ildefonso, Jingwei Zheng, Ke-Ke Zhao
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88324 (2014)
PLoS ONE
PLoS ONE
PurposeTo investigate whether the polymorphism rs800292 (184G>A, I62V) in the complement factor H gene is associated with polypoidal choroidal vasculopathy (PCV) and the genetic difference between PCV and neovascular age-related macular degeneration